Gem Aromatics IPO is a Rs.451.25 crore book-built issue, comprising a fresh issue of 0.54 crore shares worth Rs.175 crore and an offer for sale of 0.85 crore shares aggregating to Rs.276.25 crore. The subscription will open on August 19, 2025, and close on August 21, 2025. Allotment is expected on August 22, 2025, with listing on BSE and NSE likely on August 26, 2025. The price band is fixed at Rs.309–Rs.325 per share, with a lot size of 46 shares (minimum retail investment Rs.14,214). For sNII, the minimum is 14 lots (Rs.2,09,300), and for bNII, it is 67 lots (Rs.10,01,650). Motilal Oswal Investment Advisors Ltd is the BRLM and Kfin Technologies Ltd is the registrar.

Table of Contents

Latest news about this IPO 

Grey market premium has remained steady on 15th August 2025

 

 

What are the promoters of Gem Aromatics IPO?   
The promoters of the company are Vipul Parekh, Kaksha Vipul Parekh, Yash Vipul Parekh, and Parekh Family Trust.

The promoters will hold 55.06% shares in the post IPO capital of the company.

What are the Objects of Gem Aromatics IPO?

The Offer comprises a Fresh Issue by the Company and an Offer for Sale by the Selling Shareholders.

The net proceeds of the Offer are proposed to be utilised in the following manner:

  1. Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by our Company and our Subsidiary, Krystal Ingredients Private Limited; Rs. 140 crore &
  2. General corporate purposes.

What is the business of Gem Aromatics?

Incorporated in October 1997, Gem Aromatics Limited is a well-established manufacturer of specialty ingredients, including essential oils, aroma chemicals, and value-added derivatives, with more than two decades of industry experience. Its product range spans from mother ingredients to advanced value-added formulations, catering to multiple end-user industries such as oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness, pain management, and personal care.

The company offers 70 products in four key categories:

  1. Mint and its derivatives

  2. Clove and its derivatives

  3. Phenol

  4. Other synthetic & natural ingredients

Market Presence & Exports
In FY25, Gem Aromatics served 225 domestic and 44 international customers across 18 countries, including the Americas, Asia, Africa, and Australia. Sales are conducted primarily on a B2B basis through direct supply, its US subsidiary Gem Aromatics LLC, and third-party agencies.

R&D & Innovation
As of March 31, 2025, the company’s in-house R&D team of 13 scientists has played a pivotal role in developing high-margin value-added derivatives, leveraging state-of-the-art technology to enhance formulations and broaden application potential.

Competitive Strengths

  • Long-standing global relationships with reputed clients

  • Diversified product portfolio across multiple high-growth sectors

  • In-house R&D capability driving product innovation

  • Strong export presence reducing over-dependence on domestic demand

Given its global footprint, deep industry relationships, and high-value product mix, Gem Aromatics is positioned to benefit from rising demand in wellness, personal care, and pharma-linked aroma solutions. However, investors should also note the cyclical nature of raw material prices and dependency on export markets.

Gem Aromatics IPO Details

 
IPO opens on  19 August, 2025
IPO closes on  21 August, 2025 
Issue Type Book Built Issue IPO
Issue Size 138,84,615 Shares /
Rs 451.25 Crore
* Fresh Issue Rs 175 Crore
* Offer for Sale  Rs 276.25 Crore
Employee Portion Rs. 10 crore
Face Value per share: Rs. 2
Price Band  Rs. 309-325
Retail Discount  Rs 0 per share
Employee discount  Rs. – per share
Retail Lot Size  46Shares
Listing will at  BSE, NSE

How are the shares offered?

Investor Category Shares Offered
QIB  Not more than 50% of the Net Offer
Retail  Not less than 35% of the Net Offer
NII  Not less than 15% of the Net Offer

How can the shares be applied?

Application Lots Shares Amount
Retail (Min) 1 46 Rs.14,950
Retail (Max) 13 598 Rs.1,94,350
S-HNI (Min) 14 644 Rs.2,09,300
S-HNI (Max) 66 3,036 Rs.9,86,700
B-HNI (Min) 67 3,082 Rs.10,01,650

 

 
IPO opens on 19 August 2025
IPO Closes on 21 August 2025
IPO Allotment on 22 August 2025
Unblocking of Asba 25 August 2025
Credit of Shares 25 Augut 2025
Listing of Shares 26 August 2025
Registered Office of the company
Gem Aromatics Ltd.
A/410, Kailas Complex, Vikhroli Powai Link
Road, Park Site,
Vikhroli (W)
Mumbai, Maharashtra, 400079
Lead Managers of the IPO
Motilal Oswal Investment Advisors ltd
Registrar to IPO
Kfin Technologies Limited
https://ipostatus.kfintech.com/

Gem Aromatics Financial Snpshot

Period Ended 31-Mar-25 31-Mar-24 31-Mar-23
Assets 534.52 368.57 295.76
Total Income 505.64 454.23 425.09
Profit After Tax 53.38 50.1 44.67
EBITDA 88.45 78.35 66.19
Net Worth 283.98 230.55 179.53
Reserves and Surplus 278.26 224.88 182.36
Total Borrowing 222.37 111.13 89.36
Amount in Rs. Crore

 

Key Performance Indicators

KPI Values
ROE 18.80%
ROCE 16.02%
Debt/Equity 0.78
RoNW 18.80%
PAT Margin 10.56%
EBITDA Margin 17.55%
Price to Book Value 5.36
EPS 10.22
PE Ratio 31.8

 

How Gem Aromatics IPO compares with the Peers?

Company Name P/E (x) RoNW (%)
Gem Aromatics 31.80 18.8
Clean Science and Technology 57.33 18.67
Privi Speciality Chemicals 50.51 16.95
Camlin Fine Sciences   -16.01
Yasho Industries 374.92 1.46
S H Kelkar and Company 42.33 5.83
Oriental Aromatics 36.97 5.2

 

# This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.

Gem Aromatics Limited – IPO Review by Paresh Gordhandas, CA & Research Analyst

Business Overview
With over two decades of experience, Gem Aromatics is a leading manufacturer of specialty ingredients — including essential oils, aroma chemicals, and value-added derivatives — catering to diverse sectors like oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness, and personal care. The company has a strong global footprint, serving 225 domestic and 44 international customers across 18 countries. A diversified portfolio of 70 products and an in-house R&D team of 13 scientists give it a competitive edge in innovation and value addition.

Financial Performance (Rs. in crore)

  • FY23–FY25 Growth: Revenue rose from Rs. 425.09 cr (FY23) to Rs. 505.64 cr (FY25), reflecting consistent top-line expansion.

  • Profitability: PAT increased from Rs. 44.67 cr to Rs. 53.38 cr over the same period. EBITDA improved from ₹Rs. 66.19 cr to Rs. 88.45 cr, indicating operational efficiency.

  • Margins: FY25 EBITDA margin stands at ~17.5%, PAT margin ~10.6% — healthy for the industry.

  • Balance Sheet: Net worth improved from Rs. 179.53 cr (FY23) to Rs. 283.98 cr (FY25). Borrowings have more than doubled to Rs. 222.37 cr, suggesting higher leverage for expansion or working capital needs.

Valuation at Rs. 325/share
At FY25 EPS of ~Rs. 9.79, the IPO is valued at a P/E of ~33.2x, which is on the higher side compared to traditional chemical peers but could be justified by the niche nature of its product mix, export orientation, and stable margins. The rising debt is a point to watch.

Strengths

  • Diversified product basket catering to multiple high-growth industries

  • Strong export presence reducing domestic demand risk

  • In-house R&D enabling higher-margin value-added products

  • Long-standing relationships with reputed domestic & global clients

Risks

  • Rising debt levels may impact leverage ratios

  • Raw material price volatility can affect margins

  • Dependence on export markets exposes business to currency and regulatory risks

Chanakya View
Gem Aromatics combines stable growth, strong client relationships, and a niche high-margin product portfolio. However, the IPO is not cheap, and the increased borrowings add a note of caution. Suitable for investors seeking long-term exposure to a specialty ingredients exporter with steady earnings, while aggressive traders may look for listing gains depending on grey market sentiment.

 

Q1. What does Gem Aromatics Limited do?

Gem Aromatics Limited manufactures specialty ingredients like essential oils, aroma chemicals, and value-added derivatives. Its products cater to oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness, pain management, and personal care industries.

Q2. How long has Gem Aromatics been in business?

TThe company’s portfolio includes advanced PV modules such as p-type monocrystalline PERC, n-tyThe company was incorporated in October 1997 and has over 25 years of experience in the specialty ingredients industry.

Q3. What is the size and structure of the Gem Aromatics IPO?

The IPO size is Rs.451.25 crore, comprising a fresh issue of Rs.175 crore and an offer for sale of RS276.25 crore. The price band is Rs.309–Rs.325 per share

Q4. How has Gem Aromatics performed financially?

In FY25, the company reported total income of ₹505.64 crore, profit after tax of ₹53.38 crore, and EBITDA of ₹88.45 crore, with margins around 10.6%

Q5. What is Chanakya’s view on the Gem Aromatics IPO?

Chanakya sees long-term potential due to its niche product mix and global footprint. However, the IPO is priced at ~33× P/E, which is on the higher side, and rising debt is a concern. Listing gains are possible if grey market sentiment stays strong.


Gem Aromatics IPO
details


Gem Aromatics IPO
dates


Gem Aromatics IPO Review

Quicklinks

Leave a Reply

Your email address will not be published. Required fields are marked *